CureVac N.V. Equity-NMS: CVAC

$13.92 0.16 (08 Aug)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$13.76
52W high :$75.68
1Y :-78.14%
5Y :-75.38%
Shares O/S :187.12 M
Market cap :2.6 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of CureVac N.V. today?

CureVac N.V. (CVAC) share price as of August 5, 2022, is $13.92. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of CureVac N.V.?

Yes, Indian Investors can invest in the CureVac N.V. (CVAC) Share by opening an international trading account with Angel One.

How can I purchase CureVac N.V. shares in India?

Purchasing CureVac N.V. (CVAC) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying CureVac N.V. (CVAC) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of CureVac N.V.?

Yes, you can purchase fractional shares of CureVac N.V. (CVAC) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of CureVac N.V.?

The market capitalization of CureVac N.V. on August 8, 2022, is $2.6 B.

In which sector CureVac N.V. belongs?

CureVac N.V. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in CureVac N.V. stocks?

In order to invest in CureVac N.V. (CVAC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About CureVac N.V.

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.